Pharmaceutical Formulation Comprising Ezetimibe

Patent No. EP2217214 (titled "Pharmaceutical Formulation Comprising Ezetimibe") was filed by Ratiopharm on Dec 9, 2008. The application was issued on Jul 19, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BULLE DRApr 19, 2018BULLE
WITTKOPPApr 19, 2018HAMM & WITTKOPP
HOFFMANN EITLEApr 18, 2018HOFFMANN EITLE
HGFApr 16, 2018HGF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2217214

RATIOPHARM
Application Number
EP08859677A
Filing Date
Dec 9, 2008
Status
Granted And Under Opposition
Jun 16, 2017
Publication Date
Jul 19, 2017